Inventor · disambiguated record
Christophe Morisseau
Also filed as: MORISSEAU CHRISTOPHE · MORISSEAU CHRISTOPHE H
21 granted patents·14 pending applications·270 citations·filing 1999–2021
94Inventor score
Top patents by PatentIndex Score
35 records- 0194US6531506B1Inhibitors of epoxide hydrolases for the treatment of hypertensionUNIV CALIFORNIA·Filed 2000·Granted Mar 11, 2003·91 cites·11 claims
- 0289US9029401B2Sorafenib derivatives as sEH inhibitorsHAMMOCK BRUCE D·Filed 2012·Granted May 12, 2015·8 cites·24 claims
- 0389US6150415AEpoxide hydrolase complexes and methods therewithUNIV CALIFORNIA·Filed 1999·Granted Nov 21, 2000·124 cites·26 claims
- 0485US7662910B2Inhibitors for the soluble epoxide hydrolaseUNIV CALIFORNIA·Filed 2005·Granted Feb 16, 2010·10 cites·58 claims
- 0584US6693130B2Inhibitors of epoxide hydrolases for the treatment of hypertensionUNIV CALIFORNIA·Filed 2002·Granted Feb 17, 2004·13 cites·8 claims
- 0683US9096532B2Pyrazole inhibitors of COX-2 and sEHHAMMOCK BRUCE D·Filed 2011·Granted Aug 4, 2015·4 cites·23 claims
- 0782US8188289B2Conformationally restricted urea inhibitors of soluble epoxide hydrolaseHAMMOCK BRUCE D·Filed 2007·Granted May 29, 2012·5 cites·19 claims
- 0880US11123311B2Methods of treating mental disordersUNIV CALIFORNIA·Filed 2016·Granted Sep 21, 2021·1 cites·16 claims
- 0979US8815951B2Inhibitors of epoxide hydrolases for the treatment of inflammationHAMMOCK BRUCE D·Filed 2006·Granted Aug 26, 2014·2 cites·11 claims
- 1075US8476043B2Inhibitors for the soluble epoxide hydrolaseHAMMOCK BRUCE D·Filed 2009·Granted Jul 2, 2013·2 cites·9 claims
- 1174US9296693B2Acyl piperidine inhibitors of soluble epoxide hydrolaseHAMMOCK BRUCE D·Filed 2011·Granted Mar 29, 2016·1 cites·2 claims
- 1274US8501783B2Conformationally restricted urea inhibitors of soluble epoxide hydrolaseHAMMOCK BRUCE D·Filed 2012·Granted Aug 6, 2013·2 cites·18 claims
- 1373US10383835B2Treatment of inflammatory disorders in non-human mammalsUNIV CALIFORNIA·Filed 2013·Granted Aug 20, 2019·1 cites·2 claims
- 1472US11225514B2Nanobodies against cystic fibrosis transmembrane conductance regulator (CFTR) inhibitory factor (Cif)UNIV CALIFORNIA·Filed 2018·Granted Jan 18, 2022·1 cites·19 claims
- 1572US8455652B2Inhibitors for the soluble epoxide hydrolaseHAMMOCK BRUCE D·Filed 2009·Granted Jun 4, 2013·1 cites·7 claims
- 1671US9029550B2Conformationally restricted urea inhibitors of soluble epoxide hydrolaseUNIV CALIFORNIA·Filed 2013·Granted May 12, 2015·1 cites·8 claims
- 1767US9034903B2Acyl piperidine inhibitors of soluble epoxide hydrolaseUNIV CALIFORNIA·Filed 2013·Granted May 19, 2015·1 cites·9 claims
- 1866US12006355B2Nanobodies against cystic fibrosis transmembrane conductance regulator (CFTR) inhibitory factor (Cif)UNIV CALIFORNIA·Filed 2021·Granted Jun 11, 2024·0 cites·2 claims
- 1966US8513302B2Reducing nephropathy with inhibitors of soluble epoxide hydrolase and epoxyeicosanoidsHAMMOCK BRUCE D·Filed 2011·Granted Aug 20, 2013·2 cites·20 claims
- 2066US2022202744A1Methods of treating mental disordersUNIV CALIFORNIA·Filed 2021·Application pending·0 cites
- 2164US2005282767A1Inhibitors of epoxide hydrolases for the treatment of hypertensionUS GOV HEALTH & HUMAN SERV·Filed 2005·Application pending·0 cites
- 2258US2020000755A1Treatment of inflammatory disorders in non-human mammalsUNIV CALIFORNIA·Filed 2019·Application pending·0 cites
- 2355US2004092487A1Inhibitors of epoxide hydrolases for the treatment of hypertensionUNIV CALIFORNIA·Filed 2003·Application pending·0 cites
- 2454US2011245331A1Inhibitors of epoxide hydrolases for the treatment of hypertensionUNIV CALIFORNIA·Filed 2011·Application pending·0 cites
- 2554US2006035869A1Inhibitors of epoxide hydrolases for the treatment of hypertensionUNIV CALIFORNIA·Filed 2005·Application pending·0 cites
- 2653US2011098322A1Preparation of novel 1,3-substituted ureas as inhibitors of soluble epoxide hydrolaseUNIV CALIFORNIA·Filed 2008·Application pending·0 cites
- 2753US2008188554A1Methods of treating avian hypertensionUNIV CALIFORNIA·Filed 2007·Application pending·0 cites
- 2851US2005026844A1Inhibitors for the soluble epoxide hydrolaseUNIV CALIFORNIA·Filed 2004·Application pending·0 cites
- 2946US2016200683A1Acyl piperidine inhibitors of soluble epoxide hydrolaseUNIV CALIFORNIA·Filed 2016·Application pending·0 cites
- 3044US11572347B2Orally available sEH/PDE4 dual inhibitorsUNIV CALIFORNIA·Filed 2018·Granted Feb 7, 2023·0 cites·25 claims
- 3144US2009215894A1Inhibition of phosphatase activity of soluble epoxide hydrolase amino terminus and uses thereofUNIV CALIFORNIA·Filed 2006·Application pending·0 cites
- 3242US2015045389A1Compounds and methods for inhibiting cif virulence factorDARTMOUTH COLLEGE·Filed 2013·Application pending·0 cites
- 3341US2009018092A1Reducing Nephropathy with Inhibitors of Soluble Epoxide Hydrolase and EpoxyeicosanoidsUNIV CALIFORNIA·Filed 2005·Application pending·0 cites
- 3440US10322118B2Compounds and methods for inhibiting Cif virulence factorDARTMOUTH COLLEGE·Filed 2015·Granted Jun 18, 2019·0 cites·5 claims
- 3540US2005164951A1Inhibitors for the soluble epoxide hydrolaseUNIV CALIFORNIA·Filed 2004·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →